Tumor targeted pro-apoptotic peptide

Cat. No. M53426

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

Tumor targeted pro-apoptotic peptide (CNGRC-GG-D(KLAKLAK)2) is an anti-tumor peptide.

Molecular Weight	2168.72
Formula	C94H174N32O22S2
CAS Number	1926163-30-5
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Apoptosis Products
23-Hydroxybetulinic acid 23-Hydroxybetulinic acid is a novel anticancer substance.
TH-302 (Evofosfamide) TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM.
Se-Methylselenocysteine Se-methylselenocysteine, a precursor of methyl selenium, has strong cancer chemoprophylaxis and antioxidant activity. Se-Methylselenocysteine has oral biological activity, can induce apoptosis.
Aloperine Aloperine is exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.
Ezatiostat Ezatiostat (TER199, TLK199) is a glutathione analog inhibitor of glutathione S-transferase (GST) P1-1. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation.

Catalog